Skip to main content
. 2017 Feb 13;11(2):189–195. doi: 10.5009/gnl15562

Fig. 1.

Fig. 1

Cumulative incidence of hepatitis B virus resistance in pivotal trials. Adapted from EASL clinical practice guidelines. J Hepatol 2012;57:167–185.24